BC Cancer - Victoria

2410 Lee Avenue
Victoria, BC, V8R 6V5

Clinical Trial Unit Manager
Philip Pollock
250-519-5597
philip.pollock@bccancer.bc.ca

Lung

MERMAID-1: A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study to Determine the Efficacy of Adjuvant Durvalumab in Combination with Platinum-based Chemotherapy in Completely Resected Stage II-III NSCLC 

MERMAID-2: A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Study of Durvalumab for the Treatment of Stage II-III NSCLC Patients with Minimal Residual Disease Following Surgery and Curative Intent Therapy 

SKYSCRAPER-03: A Phase III, Open-Label Randomized Study of Atezolizumab and Tiragolumab Compared with Durvalumab in Patients With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer who Have Not Progressed After Concurrent Platinum-Based Chemoradiation 

Cancer Type
Lung
Phase III
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
BC Cancer - Abbotsford
Open Recruiting Date
BC Cancer - Surrey
Open Recruiting Date
View on ClinicalTrials.gov

MK-7684-003A: A Phase 3, Multi-center, Randomized, Double-Blind Study of MK-7684 with Pembrolizumab as a Co-formulation (MK-7684A) Versus Pembrolizumab Monotherapy as First Line Treatment for Participants with PD-L1 Positive Metastatic Non-Small Cell Lung Cancer 

Back to top